Semaglutide Treatment Research Dosing Schedule
September 17, 2025
Semaglutide 2.5mg/1ml = 7.5mg/3ml vial
| Week | Dose in mg | Units per 1ml | Amt Used |
| 1 | 0.25 | 6 units | |
| 2 | 0.25 | 6 units | |
| 3 | 0.25 | 6 units | |
| 4 | 0.25 | 6 units | |
| 5 | 0.5 | 12 units | |
| 6 | 0.5 | 12 units | |
| 7 | 0.5 | 12 units |
|
| 8 | 0.5 | 12 units | |
| 9 | 1 | 25 units | (roughly 1ml = 100 units) |
| 10 | 1 | 25 units |
|
| 11 | 1 | 25 units | |
| 12 | 1 | 25 units |
|
| 13 | 2 | 50 units | (roughly 2ml = 200 units) |
| 14 | 2 | 50 units | |
| 15 | 2 | 50 units | (roughly 3ml = 300 units) |
| 16 | 2 | 50 units |
Research Handling & Usage Notes
-
Store the compound in a refrigerator; do not freeze.
-
Researchers may maintain the current administration level if the existing protocol is producing the desired experimental observations.
-
Dosing levels can be gradually adjusted depending on subject tolerability and study outcomes such as changes in body composition. Many studies have observed continued reductions in weight markers with slower titration schedules.
-
After approximately eight weeks, investigators may elect to increase the amount by 10 units rather than doubling.
-
If test subjects exhibit nausea or heightened side effects, revert to the previous lower level used in the protocol.
-
Incorporating additional dietary fiber into the study diet may help minimize constipation; stool softeners or MiraLAX can be included if deemed appropriate for research.
-
Continue standard exercise regimens, balanced nutrition, and any supplemental vitamins or compounds specified in the study design.
-
Providing smaller, more frequent meals may help reduce the likelihood of low-glucose symptoms during observations.